Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Trichoscopy is useful for diagnosing and monitoring hair and scalp conditions over time.

Understanding drug effects and careful monitoring are crucial for safe and effective dermatology treatments.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

A patient's allergic reaction to clozapine resolved without stopping the medication, showing the importance of blood monitoring.

Serial trichoscopy is more reliable than the modified hair pull test for tracking alopecia areata.

Albendazole treatment for echinococcosis can cause serious side effects and requires close monitoring.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Antiandrogens help manage PCOS symptoms but need careful monitoring.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Ketoconazole can treat ovarian hyperandrogenism but should be used cautiously with monitoring and birth control.

Ruxolitinib can help regrow hair in severe alopecia areata.

Radiation cystitis patients need better monitoring and early treatment due to higher readmission rates.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Hair growth serums A and C can affect hair growth genes and pathways, suggesting potential for personalized hair loss treatments.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Patients on mood stabilizers need regular health checks, but many aren't monitored properly.

Oral minoxidil shows promise in treating monilethrix-related hair loss.

The conclusion is that 24 weeks of low-dose oral minoxidil is safe for men with hair loss, with no significant changes in heart rate or blood pressure.

Lamotrigine may cause hair loss, affecting treatment compliance and health.